1. Market Research
  2. > PharmaNeuroBoost NV - Product Pipeline Review - 2013

PharmaNeuroBoost NV - Product Pipeline Review - 2013

  • December 2013
  • -
  • Global Markets Direct
  • -
  • 29 pages

PharmaNeuroBoost NV - Product Pipeline Review - 2013

Summary

Global Market Direct’s pharmaceuticals report, “PharmaNeuroBoost NV - Product Pipeline Review - 2013” provides data on the PharmaNeuroBoost NV’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, PharmaNeuroBoost NV’s corporate website, SEC filings, investor presentations and featured press releases, both from PharmaNeuroBoost NV and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- PharmaNeuroBoost NV - Brief PharmaNeuroBoost NV overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of PharmaNeuroBoost NV human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of PharmaNeuroBoost NV with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the PharmaNeuroBoost NV’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate PharmaNeuroBoost NV’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of PharmaNeuroBoost NV in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the PharmaNeuroBoost NV’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with PharmaNeuroBoost NV.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of PharmaNeuroBoost NV and identify potential opportunities in those areas.

Table Of Contents

PharmaNeuroBoost NV - Product Pipeline Review - 2013
Table of Contents

Table of Contents 2
List of Tables 3
List of Figures 4
PharmaNeuroBoost NV Snapshot 5
PharmaNeuroBoost NV Overview 5
Key Information 5
Key Facts 5
PharmaNeuroBoost NV - Research and Development Overview 6
Key Therapeutic Areas 6
PharmaNeuroBoost NV - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Pipeline Products - Combination Treatment Modalities 10
PharmaNeuroBoost NV - Pipeline Products Glance 11
PharmaNeuroBoost NV - Late Stage Pipeline Products 11
Phase III Products/Combination Treatment Modalities 11
PharmaNeuroBoost NV - Clinical Stage Pipeline Products 12
Phase II Products/Combination Treatment Modalities 12
PharmaNeuroBoost NV - Early Stage Pipeline Products 13
Preclinical Products/Combination Treatment Modalities 13
PharmaNeuroBoost NV - Drug Profiles 14
(pipamperone + citalopram) 14
Product Description 14
Mechanism of Action 14
RandD Progress 14
(pipamperone + risperidone) 16
Product Description 16
Mechanism of Action 16
RandD Progress 16
(escitalopram + pipamperone) 17
Product Description 17
Mechanism of Action 17
RandD Progress 17
(paliperidone + pipamperone) 18
Product Description 18
Mechanism of Action 18
RandD Progress 18
PNB-05 19
Product Description 19
Mechanism of Action 19
RandD Progress 19
PharmaNeuroBoost NV - Pipeline Analysis 20
PharmaNeuroBoost NV - Pipeline Products by Therapeutic Class 20
PharmaNeuroBoost NV - Pipeline Products by Target 22
PharmaNeuroBoost NV - Pipeline Products by Route of Administration 23
PharmaNeuroBoost NV - Pipeline Products by Molecule Type 24
PharmaNeuroBoost NV - Pipeline Products by Mechanism of Action 25
PharmaNeuroBoost NV - Recent Pipeline Updates 26
PharmaNeuroBoost NV - Locations And Subsidiaries 27
Head Office 27
Appendix 28
Methodology 28
Coverage 28
Secondary Research 28
Primary Research 28
Expert Panel Validation 28
Contact Us 29
Disclaimer 29



List of Tables

PharmaNeuroBoost NV, Key Information 5
PharmaNeuroBoost NV, Key Facts 5
PharmaNeuroBoost NV - Pipeline by Indication, 2013 7
PharmaNeuroBoost NV - Pipeline by Stage of Development, 2013 8
PharmaNeuroBoost NV - Monotherapy Products in Pipeline, 2013 9
PharmaNeuroBoost NV - Combination Treatment Modalities in Pipeline, 2013 10
PharmaNeuroBoost NV - Phase III, 2013 11
PharmaNeuroBoost NV - Phase II, 2013 12
PharmaNeuroBoost NV - Preclinical, 2013 13
PharmaNeuroBoost NV - Pipeline by Therapeutic Class, 2013 21
PharmaNeuroBoost NV - Pipeline by Target, 2013 22
PharmaNeuroBoost NV - Pipeline by Route of Administration, 2013 23
PharmaNeuroBoost NV - Pipeline by Molecule Type, 2013 24
PharmaNeuroBoost NV - Pipeline Products by Mechanism of Action, 2013 25
PharmaNeuroBoost NV - Recent Pipeline Updates, 2013 26



List of Figures

PharmaNeuroBoost NV - Pipeline by Top 10 Indication, 2013 7
PharmaNeuroBoost NV - Pipeline by Stage of Development, 2013 8
PharmaNeuroBoost NV - Combination Treatment Modalities in Pipeline, 2013 10
PharmaNeuroBoost NV - Pipeline by Top 10 Therapeutic Class, 2013 20
PharmaNeuroBoost NV - Pipeline by Top 10 Target, 2013 22
PharmaNeuroBoost NV - Pipeline by Top 10 Route of Administration, 2013 23
PharmaNeuroBoost NV - Pipeline by Top 10 Molecule Type, 2013 24
PharmaNeuroBoost NV - Pipeline Products by Top 10 Mechanism of Action, 2013 25



Companies Mentioned

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.